All Stories

Illumina picks up proteomics developer SomaLogic from Standard BioTools for $425M

Illumina is diving deeper into proteomics research with a $425 million plan to acquire SomaLogic, including its protein analysis platforms and certified lab services business.

Jun 23, 2025 - 16:25
 0
Illumina picks up proteomics developer SomaLogic from Standard BioTools for $425M
Illumina is diving deeper into proteomics research with a $425 million plan to acquire SomaLogic, including its protein analysis platforms and certified lab services business.
Read More

Tags:

Previous Article

Ratio, Ionetix ink separate deals to speed production of in-demand radiopharmace...

Next Article

Sanofi signs €545M deal to explore Formation’s JAK/SYK inhibitor in new indication

Related Posts

Erasca enters another era, seeks partner for ph. 3 ex-Novartis asset

Erasca enters another era, seeks partner for ph. 3 ex-N...

May 13, 2025  0

TegMine, with ex-Stemcentrx scientists at the helm, bags tech from OBI to help fuel ADC ambitions

TegMine, with ex-Stemcentrx scientists at the helm, bag...

Jun 6, 2025  0

Turkish private equity group invests $39M to support Harvard researcher’s next-gen obesity antibodies

Turkish private equity group invests $39M to support Ha...

Jun 16, 2025  0